Paratek Appoints New Vice President
BOSTON-Paratek Pharmaceuticals, Inc., has appointed S. Ken Tanaka, Ph.D, as vice president of research and development. Tanaka's primary responsibilities with Paratek will be to oversee the company's innovative tetracycline and MAR (Multiple Antibiotic Resistance) programs, and will ensure new anti-infective products that address the worldwide problem of bacterial resistance.
Tanaka has 20 years of pharmaceutical industry experience in drug discovery, evaluation, and clinical, regulatory, and market development. His work has focused on oral, parenteral, and aerosolized antibacterial and antifungal drugs for E.R. Squibb and Sons, Inc., (now Bristol Myers-Squibb), Schwarz-Pharma, Abbott Laboratories, and PathoGenesis Corporation.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
